Answers are grounded in this paper and cite their sources.
On July 1, 2004, fosinopril sodium became the angiotensin-converting-enzyme (ACE) inhibitor of choice at the San Diego Veterans Affairs Healthcare System (VAHS). Problems arose when the drug’s manufacturer decreased fosinopril’s production, as the drug’s patent was nearing expiration. The
No takes yet. Share an insight, caveat, or question.
Gates et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: